Cargando…

Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients

Toxigenic Clostridium difficile (C. difficile) carriers represent an important source in the transmission of C. difficile infection (CDI) during hospitalisation, but its prevalence and mode in patients with hepatic cirrhosis are not well established. We investigated longitudinal changes in carriage...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunbo, Gu, Hongqin, lv, Tao, Yan, Dong, Xu, Qiaomai, Gu, Silan, Shen, Ping, Quan, Jiazheng, Fang, Yunhui, Chen, Lifeng, Ye, Guangyong, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518478/
https://www.ncbi.nlm.nih.gov/pubmed/31063095
http://dx.doi.org/10.1017/S0950268819000554
_version_ 1783418457808699392
author Chen, Yunbo
Gu, Hongqin
lv, Tao
Yan, Dong
Xu, Qiaomai
Gu, Silan
Shen, Ping
Quan, Jiazheng
Fang, Yunhui
Chen, Lifeng
Ye, Guangyong
Li, Lanjuan
author_facet Chen, Yunbo
Gu, Hongqin
lv, Tao
Yan, Dong
Xu, Qiaomai
Gu, Silan
Shen, Ping
Quan, Jiazheng
Fang, Yunhui
Chen, Lifeng
Ye, Guangyong
Li, Lanjuan
author_sort Chen, Yunbo
collection PubMed
description Toxigenic Clostridium difficile (C. difficile) carriers represent an important source in the transmission of C. difficile infection (CDI) during hospitalisation, but its prevalence and mode in patients with hepatic cirrhosis are not well established. We investigated longitudinal changes in carriage rates and strain types of toxigenic C. difficile from admission to discharge among hepatic cirrhosis patients. Toxigenic C. difficile was detected in 104 (19.8%) of 526 hepatic cirrhosis patients on admission, and the carriage status changed in a portion of patients during hospitalisation. Approximately 56% (58/104) of patients lost the colonisation during their hospital stay. Among the remaining 48 patients who remained positive for toxigenic C. difficile, the numbers of patients who were positive at one, two, three and four isolations were 10 (55.6%), three (16.7%), two (11.1%) and three (16.7%), respectively. Twenty-eight patients retained a particular monophyletic strain at multiple isolations. The genotype most frequently identified was the same as that frequently identified in symptomatic CDI patients. A total of 25% (26/104) of patients were diagnosed with CDI during their hospital stay. Conclusions: Colonisation with toxigenic C. difficile strains occurs frequently in cirrhosis patients and is a risk factor for CDI.
format Online
Article
Text
id pubmed-6518478
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-65184782019-06-04 Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients Chen, Yunbo Gu, Hongqin lv, Tao Yan, Dong Xu, Qiaomai Gu, Silan Shen, Ping Quan, Jiazheng Fang, Yunhui Chen, Lifeng Ye, Guangyong Li, Lanjuan Epidemiol Infect Original Paper Toxigenic Clostridium difficile (C. difficile) carriers represent an important source in the transmission of C. difficile infection (CDI) during hospitalisation, but its prevalence and mode in patients with hepatic cirrhosis are not well established. We investigated longitudinal changes in carriage rates and strain types of toxigenic C. difficile from admission to discharge among hepatic cirrhosis patients. Toxigenic C. difficile was detected in 104 (19.8%) of 526 hepatic cirrhosis patients on admission, and the carriage status changed in a portion of patients during hospitalisation. Approximately 56% (58/104) of patients lost the colonisation during their hospital stay. Among the remaining 48 patients who remained positive for toxigenic C. difficile, the numbers of patients who were positive at one, two, three and four isolations were 10 (55.6%), three (16.7%), two (11.1%) and three (16.7%), respectively. Twenty-eight patients retained a particular monophyletic strain at multiple isolations. The genotype most frequently identified was the same as that frequently identified in symptomatic CDI patients. A total of 25% (26/104) of patients were diagnosed with CDI during their hospital stay. Conclusions: Colonisation with toxigenic C. difficile strains occurs frequently in cirrhosis patients and is a risk factor for CDI. Cambridge University Press 2019-03-28 /pmc/articles/PMC6518478/ /pubmed/31063095 http://dx.doi.org/10.1017/S0950268819000554 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Chen, Yunbo
Gu, Hongqin
lv, Tao
Yan, Dong
Xu, Qiaomai
Gu, Silan
Shen, Ping
Quan, Jiazheng
Fang, Yunhui
Chen, Lifeng
Ye, Guangyong
Li, Lanjuan
Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
title Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
title_full Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
title_fullStr Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
title_full_unstemmed Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
title_short Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
title_sort longitudinal investigation of carriage rates and genotypes of toxigenic clostridium difficile in hepatic cirrhosis patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518478/
https://www.ncbi.nlm.nih.gov/pubmed/31063095
http://dx.doi.org/10.1017/S0950268819000554
work_keys_str_mv AT chenyunbo longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT guhongqin longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT lvtao longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT yandong longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT xuqiaomai longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT gusilan longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT shenping longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT quanjiazheng longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT fangyunhui longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT chenlifeng longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT yeguangyong longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients
AT lilanjuan longitudinalinvestigationofcarriageratesandgenotypesoftoxigenicclostridiumdifficileinhepaticcirrhosispatients